Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Minder kans op langdurige vermoeidheidsklachten na infectie met omikronvariant
mrt 2025 | Vaccinatie, Virale infecties